CERT * Stock Overview
Provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Certara, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$359.40 |
| 52 Week High | US$360.00 |
| 52 Week Low | US$302.00 |
| Beta | 1.57 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -0.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| CERT * | MX Healthcare Services | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how CERT * performed against the MX Healthcare Services industry.
Return vs Market: Insufficient data to determine how CERT * performed against the MX Market.
Price Volatility
| CERT * volatility | |
|---|---|
| CERT * Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: CERT * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CERT *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,177 | Bill Feehery | www.certara.com |
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers’ new drugs through the regulatory submission process and into the market.
Certara, Inc. Fundamentals Summary
| CERT * fundamental statistics | |
|---|---|
| Market cap | Mex$69.64b |
| Earnings (TTM) | Mex$266.15m |
| Revenue (TTM) | Mex$6.06b |
261.7x
P/E Ratio11.5x
P/S RatioIs CERT * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CERT * income statement (TTM) | |
|---|---|
| Revenue | US$335.64m |
| Cost of Revenue | US$132.58m |
| Gross Profit | US$203.07m |
| Other Expenses | US$188.34m |
| Earnings | US$14.73m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 08, 2023
| Earnings per share (EPS) | 0.092 |
| Gross Margin | 60.50% |
| Net Profit Margin | 4.39% |
| Debt/Equity Ratio | 27.1% |
How did CERT * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/28 15:13 |
| End of Day Share Price | 2023/01/29 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Certara, Inc. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Luke Sergott | Barclays |
| Andrew Moss | BofA Global Research |